The Best Biomarkers to Track for Longevity in 2026
By Riley Cho·

Introduction
The most useful longevity biomarkers in 2026 are HbA1c, apoB, hs-CRP, fasting insulin, and a validated biological age score like PhenoAge or GrimAge. These five give you a clearer read on how you are aging than a standard annual physical, and they respond to changes in sleep, training, and nutrition within months. Standard lipid panels and BMI, by contrast, miss the metabolic and inflammatory signals that actually drive age-related disease. For a professional audience already fluent in dashboards, this is the equivalent of moving from vanity metrics to real telemetry. The panels below are the ones worth paying for.
Key Takeaways:
Prioritize HbA1c, apoB, hs-CRP, fasting insulin, and a biological age score over generic annual bloodwork.
Test twice a year if you are actively intervening, once a year if your markers are stable and in optimal range.
Consumer panels like InsideTracker are useful for trend tracking, but clinical-grade labs remain the standard for apoB and advanced inflammation markers.

The Core Biomarkers Worth Tracking
Longevity science has narrowed considerably over the last five years. The consensus among researchers publishing through the Biomarkers of Aging Consortium is that a small set of blood markers, tracked over time, predicts healthspan far better than any single number. The best longevity biomarkers combine metabolic, cardiovascular, and inflammatory signals, because aging is not one process but several running in parallel.
Metabolic and Cardiovascular Markers
Metabolic health is the foundation of most age reversal biomarkers because glucose dysregulation and lipid particle burden drive the majority of preventable chronic disease. Standard lipid panels are not enough. What you want is particle count and long-term glycemic control, not just total cholesterol.
HbA1c: Reflects average blood glucose over roughly three months, with an optimal hba1c target for health span in the 4.9 to 5.3 range.
ApoB: Counts atherogenic lipoprotein particles directly, and is now considered a better cardiovascular predictor than LDL-C alone.
Fasting insulin: Catches insulin resistance years before glucose or HbA1c drift upward.
HDL to triglyceride ratio: A cleaner metabolic signal than the traditional hdl ldl ratio for longevity, especially in lean, active adults.
Lp(a): A genetically determined marker worth measuring once in your life to flag inherited cardiovascular risk.
Inflammatory and Biological Age Markers
Chronic low-grade inflammation, often called inflammaging, correlates strongly with age-related decline across nearly every organ system. Hs-CRP is the entry-level test, but IL-6 and homocysteine add resolution when you are trying to distinguish transient inflammation from a persistent baseline. Pairing these with a composite biological age score is where most serious protocols land in 2026. Composite scores like PhenoAge draw on clinical biomarkers, and newer methylation-based clocks such as GrimAge estimate biological age from DNA methylation patterns. For readers already using inflammation markers tracking at home, the natural next step is layering a biological age score on top once or twice a year.

Testing Options for Tech Professionals
The testing landscape has fractured into three tiers: consumer subscription panels, direct-to-consumer clinical labs, and full concierge longevity clinics. Each serves a different use case, and picking the wrong tier is how most people either overspend or undertest. The right choice depends on how actively you are intervening and how much interpretation you want handled for you.
Consumer Panels vs Clinical Labs
The InsideTracker vs standard blood panels debate misses the point. They solve different problems. Consumer platforms optimize for trend tracking and behavior change, while clinical labs give you the specific advanced markers your primary care doctor can actually act on. Most serious trackers use both. Here is how the main options compare for a US-based professional audience, alongside physician-reviewed at-home biomarker testing as another entry point into this tier.
Option | Price Range | Key Markers | Best For |
|---|---|---|---|
InsideTracker Ultimate | $500 to $700 | 48+ blood markers, no apoB | Trend tracking with lifestyle recommendations |
Function Health | $500/year | 100+ markers including apoB, Lp(a) | Comprehensive annual scan with clinician review |
Quest or Labcorp direct | $150 to $400 | Any marker you order | Targeted testing when you know what you need |
Concierge longevity clinic | $3,000 to $15,000+ | Advanced panels plus imaging | Full protocol design and ongoing intervention |
TruDiagnostic (biological age) | $300 to $500 | Methylation-based age clocks | Adding a biological age score to existing panels |
The main tradeoff: subscription panels give you frequency and coaching but skip a few high-value markers, while direct clinical lab orders give you exact control at lower cost but require you to interpret results yourself. For most professionals, Function Health or an equivalent paired with a once-a-year biological age test hits the right balance. Concierge is worth it only when you are running structured interventions and need someone accountable for the protocol. The biological age testing guide covers how to sequence these tests without duplicating spend.
How Often to Test
Testing cadence matters more than panel breadth. If your markers are stable and already in optimal range, once a year is enough. If you are actively changing something, whether that is a new training block, a dietary shift, or a supplement stack, retest the affected markers at 90 to 120 days to see whether the intervention is working. Biological age clocks are noisier than individual biomarkers, so treat single readings with skepticism and look for direction over three to four measurements. Some professionals pair blood work with continuous data from wearables, and the wearables versus blood tests tradeoff is worth understanding before spending on both.

Making Biomarker Data Actionable
Collecting data is the easy part. The harder work is turning a spreadsheet of numbers into decisions about how you eat, train, sleep, and supplement. Most people who quit longevity tracking do so because they never build a feedback loop between the numbers and their behavior.
Building a Personal Baseline
Establish your baseline before you start intervening. Run a full panel, then wait 90 days without changing anything major, and run it again. This tells you which markers naturally fluctuate for you and which are truly stable. Only after you have that reference should you start layering interventions, one variable at a time. Coverage of quantified self platforms often glosses over this step, but it is what separates people who see real progress from those chasing noise. Peer-reviewed work on aging biomarker validity reinforces that reliability across repeat measurements is what makes a marker useful for tracking interventions.
Connecting Data to Decisions
The point of tracking longevity health metrics for professionals is not the numbers themselves but the decisions they enable. Elevated fasting insulin might push you toward earlier dinners and lower carbohydrate intake in the evening. Rising hs-CRP might prompt a closer look at sleep quality, alcohol, or overtraining. Climbing apoB might mean adding fiber, statins, or both after a conversation with a physician. TechBriefed readers who follow developments in precision health startups know the space is moving quickly, with new biological age measurement methods emerging every year, but the discipline of connecting one data point to one action has not changed. Independent analysis of these tools, the kind TechBriefed publishes for the tech industry, helps cut through vendor claims and focus on what is clinically meaningful.
Conclusion
The best longevity biomarkers are the ones you will actually retest and act on. HbA1c, apoB, hs-CRP, fasting insulin, and a biological age score cover the metabolic, cardiovascular, and inflammatory territory that matters most, and they respond to real behavior change within a testing cycle or two. Pick a panel provider that matches your intervention pace, establish a baseline before changing variables, and treat single readings as directional rather than definitive. TechBriefed will continue to cover the precision health tools and platforms shaping this space so professionals can spend less time evaluating vendors and more time acting on their data. The tracking only pays off when it drives decisions.
Want a sharper signal on the tools reshaping precision health and quantified self? Subscribe to TechBriefed for daily analysis on the tech and health platforms worth your attention.
Frequently Asked Questions (FAQs)
What are the best biomarkers to track for longevity?
The most actionable set includes HbA1c, apoB, hs-CRP, fasting insulin, and a validated biological age score like PhenoAge or GrimAge.
How do I measure my biological age?
Use a methylation-based clock like GrimAge or TruDiagnostic, or calculate PhenoAge from a standard blood panel that includes albumin, creatinine, glucose, and CRP.
Why should tech professionals track longevity biomarkers?
Because early metabolic and inflammatory signals appear years before clinical disease, and catching them lets you intervene while the changes are still cheap and reversible.
Can blood tests accurately predict your lifespan?
No single test predicts lifespan, but composite biological age scores built from multiple blood markers correlate meaningfully with future healthspan and disease risk.
What is the most important biomarker for aging?
ApoB and fasting insulin are the two most predictive individual markers because they capture cardiovascular and metabolic risk earlier than most standard tests.
How often should you test longevity biomarkers?
Once a year if your markers are stable, or every 90 to 120 days when you are actively running an intervention and want to measure its effect.
Is insulin resistance a longevity biomarker?
Yes, fasting insulin and HOMA-IR are among the earliest signals of metabolic dysfunction and are strong predictors of age-related disease decades ahead of diagnosis.